1 / 6

cardiovascular monitoring and diagnostic devices

The Cardiovascular Monitoring and Diagnostic Devices Market is Forecast to Exceed $1.2 billion by 2017

rgunnam
Download Presentation

cardiovascular monitoring and diagnostic devices

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Cardiovascular Monitoring and Diagnostic Devices -Global Pipeline Analysis, Competitive Landscapeand Market Forecasts to 2017

  2. The Cardiovascular Monitoring and Diagnostic Devices Market is Forecast to Exceed $1.2 billion by 2017 The global Cardiovascular Monitoring and Diagnostic (CMD) devices market is forecast to reach $1.2 billion by 2017, growing at a Compound Annual Growth Rate (CAGR) of 5% during 2010-2017. This market includes Electrocardiograph (ECG) monitoring equipment, Holter monitoring systems, ECG stress testing systems, event monitoring systems, ECG data monitoring systems, cardiopulmonary stress testing systems, cardiovascular monitoring and diagnostic devices. ECG monitoring equipment was the largest segment, growing at 4% over the period 2010-2017 and valued at $410.5m in 2010. The growth in this market will be spurred on by an increase in the population of patients with cardiovascular disorders such as cardiac arrhythmias, Congestive Heart Failure (CHF) and myocardial ischemia, and the widespread use of ECG monitoring equipment as a basic diagnostic tool to measure abnormal heart events. ECG monitoring equipment, equipped with advanced technology and coupled with exceptional communication capabilities, is expected to be a key driver for the growth of the CMD devices market. Furthermore, the CMD devices market offers steady growth opportunities due to increasing healthcare delivery at private physician offices. The US Remains the Largest Cardiovascular Monitoring and Diagnostic Devices Market

  3. The US was the biggest market for CMD devices in 2010, contributing 44% to the global CMD devices market. The US CMD devices market was valued at $385.6m in 2010, and is expected to grow at a CAGR of 4% to reach $514.7m in 2017. Ageing population and growing prevalence of cardiovascular diseases are expected to play a major role in the growth of the market. The market is also expected to receive a boost from the recent healthcare reforms that have proposed insurance coverage for nearly 40 million previously uninsured people. However, low reimbursement levels, rising pressure on the healthcare infrastructure and impending healthcare reforms will shift the focus towards cost effective solutions. Along with this, continuing focus on price to gain a competitive advantage will further dampen the prospects for market growth. ECG Telemetry Devices Set to Remain a Key Trend in Cardiovascular Monitoring and Diagnostic Devices The CMD devices market is particularly characterized by the emergence of various novel technologies, with Mobile Cardiac Outpatient Telemetry (MCOT) and wireless ECG monitoring systems expected to For further details, please click or add the below link to your browser: http://www.globaldata.com/reportstore/Report.aspx?ID=Cardiovascular-Monitoring-and-Diagnostic-Devices-Global-Pipeline-Analysis-Competitive-Landscape-and-Market-Forecasts-to-2017&Title=Medical_Devices&ReportType=Industry_Report

  4. drive future growth of the market. The need to observe arrhythmia patients for an extended period of time, while ensuring accuracy and increasing compliance, has led to the development of homebound outpatient telemetry services for patients suffering from post Coronary Artery Bypass Surgery (CABG), atrial fibrillation, and for drug management for patients. ECG telemetry devices are highly useful in addressing the needs of patients who are most prone to cardiac problems during ambulation. ECG telemetry devices monitor patients for cardio respiratory dysfunction, and at the same time allow patients to be ambulatory during hospital stays. The technology is used to provide uninterrupted transmission from the patient to the monitoring station. In addition to the transmission of ECG data, telemetric monitoring devices also relay data associated with blood pressure, and hemoglobin oxygen saturation. Such a complete range of data facilitates physicians to determine vital physiological changes in the patient, and take appropriate treatment measures. Emerging Economies Hold Significant Potential for the Cardiovascular Monitoring and Diagnostic Devices Market Emerging markets offer strong growth opportunities for the CMD devices market. The CMD devices markets in China, Brazil and India are expected to grow at a higher than average rate in 2010–2017, at 8%, 9% and 12% respectively. Emerging markets offer new opportunities for CMD companies who are witnessing slower growth in mature markets such as the US and the European

  5. Union (EU). The strong growth in emerging countries is primarily driven by rising income levels, along with a rising level of healthcare access and funding. The governments in these countries are taking steps towards improving healthcare quality and access to the latest medical advances. In addition, emerging countries are expected to register higher growth rates due to the booming medical tourism industry and the immense growth opportunities and manufacturing cost advantages in countries such as India and China. GE Healthcare, Philips Healthcare, Fukuda Denshi, Nihon Kohden and Cardiac Science Corporation weren the leading companies in the CMD devices market in 2010. The CMD devices market is fairly consolidated, with the top five companies accounting for about 60% of the market. GE Healthcare was the market leader with 21% share, and is expected to maintain its leadership position in the future with a strong focus on innovation. Philips Healthcare, Fukuda Denshi, Nihon Kohden and Cardiac Science Corporation accounted for 16%, 9%, 8% and 8% respectively. GlobalData’s new report, “Cardiovascular Monitoring and Diagnostic Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017” provides key data, information and analysis on the global cardiovascular monitoring and diagnostic devices market. The report provides market landscape, competitive landscape and market trends information on the cardiovascular monitoring and diagnostic devices market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics.

  6. The report also reviews the competitive landscape and technology offerings. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts For further details, please click or add the below link to your browser: http://www.globaldata.com/reportstore/Report.aspx?ID=Cardiovascular-Monitoring-and-Diagnostic-Devices-Global-Pipeline-Analysis-Competitive-Landscape-and-Market-Forecasts-to-2017&Title=Medical_Devices&ReportType=Industry_Report Visit our report store: http://www.globaldata.com For more details contact: pressreleases@globaldata.com North America: +1 646 395 5477 Europe: +44 207 753 4299 +44 1204 543 533 Asia Pacific: +91 40 6616 6782

More Related